Early Detection of Pressure Induced Tissue Damage by Infrared Spectroscopy (ODP) Device
1 other identifier
interventional
31
1 country
1
Brief Summary
The aim of this study is to demonstrate that infrared spectroscopy is able to detect pressure injuries at a very early stage
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 25, 2018
CompletedFirst Posted
Study publicly available on registry
May 8, 2018
CompletedStudy Start
First participant enrolled
July 30, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 12, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 12, 2021
CompletedApril 28, 2022
April 1, 2022
2.8 years
April 25, 2018
April 27, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
Early detection of pressure induced tissue damage
Infrared spectroscopy will indicate on a system-defined scale (yes/no) whether or not the subject has a pressure injury
Ten minutes
Pressure injury probability
Infrared spectroscopy will calculate using accepted statistical tools the probability of the subject getting a pressure injury within the next few days
Ten minutes
Study Arms (1)
Suspected pressure injury
EXPERIMENTALPatients evaluated with high-risk for pressure injury
Interventions
Infrared spectroscopy device will be used to detect non-visible pressure injuries
Eligibility Criteria
You may qualify if:
- Patients with stage 1 pressure injury
- Patients with high risk of developing pressure injury
You may not qualify if:
- Patients with stage 2 pressure injury or higher
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rambam healrh care campus
Haifa, Israel
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Plastic Surgery Department
Study Record Dates
First Submitted
April 25, 2018
First Posted
May 8, 2018
Study Start
July 30, 2018
Primary Completion
May 12, 2021
Study Completion
May 12, 2021
Last Updated
April 28, 2022
Record last verified: 2022-04
Data Sharing
- IPD Sharing
- Will not share